
TRLV Stock Forecast & Price Target
TRLV Analyst Ratings
Bulls say
Trulieve Cannabis is a well-positioned vertically integrated cannabis company with a dominant market share in Florida and strong growth opportunities in Georgia, Pennsylvania, and Texas. The company's strong financial performance, with 2Q26 EBITDA of $98M, SG&A of $102M, and revenue of $271M, highlights its ability to execute and maintain profitability in its core markets. In addition to its current success, Trulieve also has multiple potential catalysts, including federal regulatory reform and potential adult-use legalization in various states, that could further drive growth and profitability.
Bears say
Trulieve Cannabis is facing numerous headwinds that may negatively impact its future growth potential. These include delayed regulatory approvals, a restrictive regulatory framework in Alabama, and relatively limited growth opportunities in West Virginia. Furthermore, while Trulieve has a strong foothold in Florida's medical-only market and is expanding into other states, it faces competition in these markets and may face challenges in gaining regulatory approval. These factors could limit earnings growth and result in a lower valuation for Harvest, which Trulieve is planning to reconsolidate.
This aggregate rating is based on analysts' research of Trulieve Cannabis Corp and is not a guaranteed prediction by Public.com or investment advice.
TRLV Analyst Forecast & Price Prediction
Start investing in TRLV
Order type
Buy in
Order amount
Est. shares
0 shares